Varon says some of his patients still have diarrhea after meals years after stopping GLP-1s, though the link to the drugs wasn't established.
Recap by typeshit. Full story at WPEC.
A shared explainer on how eating habits and food choices matter once you begin a GLP-1 medication. General guidance, no new findings.
Williams explains how retatrutide's glucagon pathway works and cautions that knockoff Reta sold online is a real risk. FDA approval could come in late 2027 or 2028.
A brief post argues buyers need accurate information on peptides because a lot of the popular messaging is misleading.
Men's Journal reports the coroner's findings on the cause of Norton's death, with the dose detail coming from the coroner rather than earlier speculation.
Gounder notes the policy requires no testing of finished vials or deadline for side effect reports, and public comments on the draft run through November 13.
Healio
Durrani tells Healio the move bypassed rulemaking and FDA scientists, and warns patients may wrongly read it as FDA approval while long-term data is missing.
Loading…